SLC1A5 and pancreatic neoplasm: It is irrefutable that glutamine uptake also affects chemotherapy sensitivity, as shown by higher levels of SLC1A5 (glutamine transporter) in CR lung cancer cells when compared to wild-type cells [87] and chemoresistance induction upon SLC1A5 overexpression in pancreatic cancer cells [88].